Monica Torres-Fonseca

Pathophysiology of abdominal aortic aneurysm: biomarkers and novel therapeutic targets

L. Blanco-Colio, J. Martín-Ventura, M. Orriols, 2019, Clínica e Investigación en Arteriosclerosis (English Edition).

Increased galectin-3 levels are associated with abdominal aortic aneurysm progression and inhibition of galectin-3 decreases elastase-induced AAA development.

J. Egido, L. Blanco-Colio, J. Martín-Ventura, 2017, Clinical science.

Paraoxonase-1 overexpression prevents experimental abdominal aortic aneurysm progression.

J. Egido, J. López, L. Blanco-Colio, 2016, Clinical science.

ApoA-I/HDL-C levels are inversely associated with abdominal aortic aneurysm progression

J. Michel, E. Calvo, J. Egido, 2015, Thrombosis and Haemostasis.

Lipocalin-2 deficiency or blockade protects against aortic abdominal aneurysm development in mice.

T. Mak, J. Egido, C. Pastor-Vargas, 2016, Cardiovascular research.

Impaired HDL (High-Density Lipoprotein)-Mediated Macrophage Cholesterol Efflux in Patients With Abdominal Aortic Aneurysm—Brief Report

M. Jauhiainen, J. Metso, J. Lindholt, 2018, Arteriosclerosis, thrombosis, and vascular biology.

From tissue iron retention to low systemic haemoglobin levels, new pathophysiological biomarkers of human abdominal aortic aneurysm

J. Michel, T. Lefèbvre, L. Gouya, 2014, Thrombosis and Haemostasis.

Label‐free proteomic analysis of red blood cell membrane fractions from abdominal aortic aneurysm patients

J. Michel, J. Egido, J. López, 2014, Proteomics. Clinical applications.

Pathophisiology of abdominal aortic aneurysm: biomarkers and novel therapeutic targets.

L. Blanco-Colio, J. Martín-Ventura, J. L. Martín-Ventura, 2019, Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis.